Therma Bright Inc. (TBRIF)
USD 0.02
(-0.93%)
USD 0.02
(-0.93%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 2.16 Million CAD | 72.68% |
| 2022 | 1.25 Million CAD | 35.22% |
| 2021 | 927.11 Thousand CAD | 0.3% |
| 2020 | 924.31 Thousand CAD | 150.14% |
| 2019 | 369.51 Thousand CAD | -10.49% |
| 2018 | 412.83 Thousand CAD | -60.48% |
| 2017 | 1.04 Million CAD | -35.77% |
| 2016 | 1.62 Million CAD | 14.49% |
| 2015 | 1.42 Million CAD | -74.48% |
| 2014 | 5.56 Million CAD | -1.79% |
| 2013 | 5.66 Million CAD | -14.28% |
| 2012 | 6.61 Million CAD | 13.3% |
| 2011 | 5.83 Million CAD | 0.0% |
| 2009 | 5.02 Million CAD | 36.54% |
| 2008 | 3.68 Million CAD | 31.69% |
| 2007 | 2.79 Million CAD | 14.52% |
| 2006 | 2.44 Million CAD | 59.61% |
| 2005 | 1.52 Million CAD | 138.01% |
| 2004 | 642.55 Thousand CAD | 819.46% |
| 2003 | 69.88 Thousand CAD | 736.83% |
| 2002 | 8351.00 CAD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 2.2 Million CAD | 4.03% |
| 2024 Q1 | 2.12 Million CAD | -2.0% |
| 2024 Q3 | 2.62 Million CAD | 18.79% |
| 2023 Q1 | 1.16 Million CAD | -7.0% |
| 2023 Q3 | 1.16 Million CAD | -1.03% |
| 2023 Q4 | 2.16 Million CAD | 85.68% |
| 2023 Q2 | 1.17 Million CAD | 1.04% |
| 2023 FY | 2.16 Million CAD | 72.68% |
| 2022 Q1 | 882.21 Thousand CAD | -4.84% |
| 2022 FY | 1.25 Million CAD | 35.22% |
| 2022 Q4 | 1.25 Million CAD | -8.67% |
| 2022 Q2 | 1.28 Million CAD | 46.14% |
| 2022 Q3 | 1.37 Million CAD | 6.46% |
| 2021 Q1 | 261.26 Thousand CAD | -71.73% |
| 2021 Q4 | 927.11 Thousand CAD | 122.55% |
| 2021 Q3 | 416.58 Thousand CAD | -26.34% |
| 2021 Q2 | 565.52 Thousand CAD | 116.46% |
| 2021 FY | 927.11 Thousand CAD | 0.3% |
| 2020 Q2 | 470.78 Thousand CAD | 15.8% |
| 2020 Q3 | 561.53 Thousand CAD | 19.27% |
| 2020 FY | 924.31 Thousand CAD | 150.14% |
| 2020 Q4 | 924.31 Thousand CAD | 64.61% |
| 2020 Q1 | 406.56 Thousand CAD | 10.03% |
| 2019 Q1 | 294.17 Thousand CAD | -28.74% |
| 2019 Q2 | 445.22 Thousand CAD | 51.35% |
| 2019 Q3 | 622.29 Thousand CAD | 39.77% |
| 2019 Q4 | 369.51 Thousand CAD | -40.62% |
| 2019 FY | 369.51 Thousand CAD | -10.49% |
| 2018 FY | 412.83 Thousand CAD | -60.48% |
| 2018 Q1 | 1.06 Million CAD | 1.99% |
| 2018 Q3 | 580.98 Thousand CAD | 85.11% |
| 2018 Q2 | 313.86 Thousand CAD | -70.54% |
| 2018 Q4 | 412.83 Thousand CAD | -28.94% |
| 2017 FY | 1.04 Million CAD | -35.77% |
| 2017 Q2 | 1.73 Million CAD | 2.95% |
| 2017 Q3 | 1.09 Million CAD | -36.7% |
| 2017 Q4 | 1.04 Million CAD | -4.76% |
| 2017 Q1 | 1.68 Million CAD | 3.49% |
| 2016 FY | 1.62 Million CAD | 14.49% |
| 2016 Q1 | 1.54 Million CAD | 8.94% |
| 2016 Q3 | 1.63 Million CAD | 2.14% |
| 2016 Q2 | 1.6 Million CAD | 3.48% |
| 2016 Q4 | 1.62 Million CAD | -0.57% |
| 2015 Q2 | 1.27 Million CAD | -78.12% |
| 2015 Q4 | 1.42 Million CAD | 4.72% |
| 2015 FY | 1.42 Million CAD | -74.48% |
| 2015 Q1 | 5.81 Million CAD | 4.43% |
| 2015 Q3 | 1.35 Million CAD | 6.68% |
| 2014 Q4 | 5.56 Million CAD | -12.11% |
| 2014 Q2 | 6.09 Million CAD | 4.14% |
| 2014 Q1 | 5.85 Million CAD | 3.32% |
| 2014 Q3 | 6.33 Million CAD | 3.85% |
| 2014 FY | 5.56 Million CAD | -1.79% |
| 2013 Q4 | 5.66 Million CAD | -21.15% |
| 2013 Q2 | 6.98 Million CAD | 2.79% |
| 2013 Q1 | 6.79 Million CAD | 2.74% |
| 2013 FY | 5.66 Million CAD | -14.28% |
| 2013 Q3 | 7.18 Million CAD | 2.94% |
| 2012 Q4 | 6.61 Million CAD | 0.0% |
| 2012 FY | 6.61 Million CAD | 13.3% |
| 2011 FY | 5.83 Million CAD | 0.0% |
| 2010 Q2 | 5.18 Million CAD | 1.53% |
| 2010 Q3 | 5.25 Million CAD | 1.47% |
| 2010 Q1 | 5.1 Million CAD | 1.56% |
| 2009 FY | 5.02 Million CAD | 36.54% |
| 2009 Q4 | 5.02 Million CAD | 12.72% |
| 2009 Q1 | 3.94 Million CAD | 7.12% |
| 2009 Q3 | 4.45 Million CAD | 3.81% |
| 2009 Q2 | 4.29 Million CAD | 8.94% |
| 2008 Q2 | 3.25 Million CAD | 11.62% |
| 2008 FY | 3.68 Million CAD | 31.69% |
| 2008 Q4 | 3.68 Million CAD | 7.0% |
| 2008 Q3 | 3.44 Million CAD | 5.63% |
| 2008 Q1 | 2.91 Million CAD | 4.39% |
| 2007 Q1 | 2.55 Million CAD | 4.7% |
| 2007 Q2 | 2.47 Million CAD | -3.25% |
| 2007 FY | 2.79 Million CAD | 14.52% |
| 2007 Q3 | 2.52 Million CAD | 2.0% |
| 2007 Q4 | 2.79 Million CAD | 10.84% |
| 2006 Q4 | 2.44 Million CAD | -5.83% |
| 2006 Q3 | 2.59 Million CAD | 11.68% |
| 2006 FY | 2.44 Million CAD | 59.61% |
| 2006 Q2 | 2.32 Million CAD | 42.57% |
| 2006 Q1 | 1.62 Million CAD | 6.46% |
| 2005 FY | 1.52 Million CAD | 138.01% |
| 2005 Q3 | 901.09 Thousand CAD | 17.54% |
| 2005 Q1 | 678.03 Thousand CAD | 0.0% |
| 2005 Q2 | 766.63 Thousand CAD | 13.07% |
| 2005 Q4 | 1.52 Million CAD | 69.72% |
| 2004 Q2 | 253.89 Thousand CAD | 54.97% |
| 2004 FY | 642.55 Thousand CAD | 819.46% |
| 2004 Q1 | 163.84 Thousand CAD | 114.03% |
| 2004 Q3 | 14.95 Thousand CAD | -94.11% |
| 2003 FY | 69.88 Thousand CAD | 736.83% |
| 2003 Q1 | 69.88 Thousand CAD | -80.58% |
| 2003 Q4 | 76.55 Thousand CAD | -31.63% |
| 2003 Q3 | 111.97 Thousand CAD | 80.44% |
| 2003 Q2 | 62.05 Thousand CAD | -11.2% |
| 2002 FY | 8351.00 CAD | 0.0% |
| 2002 Q3 | 559.15 Thousand CAD | 67.12% |
| 2002 Q4 | 359.84 Thousand CAD | -35.65% |
| 2002 Q2 | 334.57 Thousand CAD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Manhattan Scientifics, Inc. | 2.11 Million USD | -2.207% |
| SS Innovations International, Inc. | 11.18 Million USD | 80.639% |
| Össur hf. | 688.8 Million USD | 99.686% |
| Össur hf. | 688.8 Million USD | 99.686% |
| CVR Medical Corp. | - USD | -Infinity% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| QHSLab, Inc. | 2.05 Million USD | -5.235% |
| BrainsWay Ltd. | 15.31 Million USD | 85.864% |
| BioElectronics Corporation | 16.62 Million USD | 86.977% |
| AVITA Medical, Inc. | 19.86 Million USD | 89.103% |
| Zecotek Photonics Inc. | 5.86 Million USD | 63.113% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| Wellstar International, Inc. | 55.99 Million USD | 96.134% |
| Hamilton Thorne Ltd. | 45.84 Million USD | 95.278% |
| EKF Diagnostics Holdings plc | 16.08 Million USD | 86.538% |
| Escalon Medical Corp. | 2.94 Million USD | 26.578% |
| Aurora Spine Corporation | 6.65 Million USD | 67.465% |
| NewCardio, Inc. | 6.01 Million USD | 63.997% |
| Avitar, Inc. | 11.59 Million USD | 81.328% |
| Vivos Inc. | 245 Thousand USD | -783.555% |
| Theraclion SA | 13.01 Million EUR | 83.369% |
| Kelyniam Global, Inc. | 1.01 Million USD | -113.71% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| REMSleep Holdings, Inc. | 275.61 Thousand USD | -685.426% |
| Positron Corporation | 2.02 Million USD | -6.848% |
| CYduct Diagnostics, Inc. | 2.44 Million USD | 11.636% |
| Nanomix Corporation | 14.81 Million USD | 85.388% |
| Wellness Center USA, Inc. | 5.12 Million USD | 57.754% |
| Stratec SE | 271.97 Million USD | 99.204% |
| Heart Tronics, Inc. | 1.09 Million USD | -97.732% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Nu-Med Plus, Inc. | 2.35 Million USD | 8.226% |
| Electromedical Technologies, Inc. | 3.62 Million USD | 40.22% |
| Lombard Medical, Inc. | 53.79 Million USD | 95.976% |
| ALR Technologies Inc. | 24.5 Million USD | 91.166% |
| MicroPort Scientific Corporation | 2.48 Billion USD | 99.913% |
| Vycor Medical, Inc. | 4.31 Million USD | 49.864% |
| VMS Rehab Systems, Inc. | 201.36 USD | -1074962.078% |
| Perimeter Medical Imaging AI, Inc. | 5.47 Million USD | 60.473% |
| Guided Therapeutics, Inc. | 5.47 Million USD | 60.461% |
| SANUWAVE Health, Inc. | 65.59 Million USD | 96.7% |
| Ingen Technologies, Inc. | 5.7 Million USD | 62.086% |
| United American Healthcare Corporation | 119 Thousand USD | -1719.113% |
| Odyssey Group International, Inc. | 6.61 Million USD | 67.259% |
| IR-Med Inc. | 634 Thousand USD | -241.442% |
| Polarean Imaging plc | 2.58 Million USD | 16.113% |
| ECGI Holdings, Inc. | 11.94 Million USD | 81.87% |
| Capital Group Holdings, Inc. | 1.32 Million USD | -63.502% |
| ADM Tronics Unlimited, Inc. | 1.44 Million USD | -49.671% |
| Medical Supply International USA, Inc. | 677.61 Thousand USD | -219.465% |
| Urologix, Inc. | 12.64 Million USD | 82.879% |
| Rapid Therapeutic Science Laboratories, Inc. | 5.39 Million USD | 59.883% |
| Nexeon MedSystems Inc. | 8.48 Million USD | 74.48% |
| Qualis Innovations, Inc. | 525.38 Thousand USD | -312.029% |
| Smith & Nephew plc | 4.76 Billion USD | 99.955% |
| NIOX Group Plc | 9.8 Million USD | 77.915% |
| Fuse Medical, Inc. | 15.11 Million USD | 85.673% |
| Broncus Holding Corporation | 10.43 Million USD | 79.249% |
| Brain Scientific Inc. | 7.42 Million USD | 70.851% |
| Pressure BioSciences, Inc. | 33.8 Million USD | 93.596% |
| Health Logic Interactive Inc. | 794.08 Thousand USD | -172.61% |